Abstract |
|
Authors | Hiroshi Nakase, Takayuki Matsumoto, Kenji Watanabe, Tadakazu Hisamatsu |
Journal | Journal of gastroenterology
(J Gastroenterol)
Vol. 55
Issue 9
Pg. 824-832
(Sep 2020)
ISSN: 1435-5922 [Electronic] Japan |
PMID | 32661927
(Publication Type: Comparative Study, Journal Article, Review)
|
Chemical References |
- Immunologic Factors
- Tumor Necrosis Factor Inhibitors
- Infliximab
- Adalimumab
|
Topics |
- Adalimumab
(administration & dosage, pharmacology)
- Crohn Disease
(drug therapy, immunology, physiopathology)
- Drug Therapy, Combination
- Evidence-Based Medicine
- Humans
- Immunologic Factors
(administration & dosage, pharmacology)
- Infliximab
(administration & dosage, pharmacology)
- Randomized Controlled Trials as Topic
- Tumor Necrosis Factor Inhibitors
(administration & dosage, pharmacology)
|